NCT07357857 (DINO-PL) is a NA clinical trial of High Five in Overweight, Childhood, sponsored by Institute of Mother and Child, Warsaw, Poland.

Who is sponsoring NCT07357857?

NCT07357857 is sponsored by Institute of Mother and Child, Warsaw, Poland.

What drugs are being tested in NCT07357857?

Interventions in NCT07357857: High Five.

What condition does NCT07357857 study?

NCT07357857 studies Overweight, Childhood, Obesity Prevention, Blood Pressure.

Is NCT07357857 still recruiting?

NCT07357857 is currently completed. Last updated 30 January 2026.

Last reviewed 2026-01-30 · How we verify

NCT07357857: DINO-PL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

High Five! - School-based Prevention of Overweight and Obesity Among 6 to 9 Year Olds

Completed NA Last updated 30 January 2026

What this trial tests

NA trial testing High Five in Overweight, Childhood in 659 participants. Completed in 28 November 2025.

Timeline

23 April 2025

Primary endpoint
28 November 2025

28 November 2025

Quick facts

Lead sponsor	Institute of Mother and Child, Warsaw, Poland
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	659
Start date	23 April 2025
Primary completion	28 November 2025
Estimated completion	28 November 2025
Sites	1 location across Poland

Drugs / interventions tested

High Five

Conditions studied

Overweight, Childhood — all drugs for Overweight, Childhood →
Obesity Prevention — all drugs for Obesity Prevention →
Blood Pressure — all drugs for Blood Pressure →

Sponsor

Institute of Mother and Child, Warsaw, Poland

Who can join

Adults 6 to 9, any sex, with Overweight, Childhood or Obesity Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this interventional study is to assess the effectiveness of the school-based "High Five!" program in reducing overweight, obesity and high blood pressure in children aged 7-9 years old. The main questions it aims to answer are: * Does participation in the "High Five!" program reduce the proportion of child participants with elevated body mass index (BMI), waist and hip circumference, and blood pressure? * Does participation in the "High Five!" program increase adherence to recommended health behaviors (healthy eating, physical activity, screen time management, and sleep hygiene) among participating children? Researchers compare "High Five!" to the school practice as usual to see if this program works to prevent overweight and related health problems in children. Students participate in 6 sessions. Sessions 1-5 are dedicated to five health-related topics such as mental health, nutrition, physical activity, screen time and sleep while session 6 serves as a summarizing and reinforcing lesson. Sessions are based on active methods (play, individual / small group work) and carried out in accordance with detailed scenarios by trained specialists: the class teacher and the school nurse. Parents/guardians of participating students are engaged in promoting healthy behaviors and creating a supportive home environment via self-reading of the "portions of knowledge" on the topics covered by the program and completion of home tasks with their children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Overweight, Childhood

Currently open trials in the same condition.

NCT06705400 — The Bloom Study - a Safe and Healthy Start in Life · NA · recruiting
NCT06432790 — Comparative-effectiveness of a Healthy Lifestyle and Asthma Management Program, In-person vs. ONline · NA · recruiting
NCT05277558 — Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D) · recruiting

Other Institute of Mother and Child, Warsaw, Poland trials

Trials by the same sponsor.

NCT06984445 — Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia · recruiting
NCT06893926 — Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction · recruiting
NCT05395741 — Regorafenib in Patients With Refractory Primary Bone Tumors · Phase 1, PHASE2 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07357857 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institute of Mother and Child, Warsaw, Poland
Last refreshed: 30 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07357857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing